Tofersen, an experimental antisense drug developed for the treatment of amyotrophic lateral sclerosis (ALS) associated with a mutation in SOD1 genes (SOD1-ALS) may have clinical benefit,...
New technologies are key to helping NASA achieve its long-term research goals for the benefit of all. To support its efforts, the agency announced on Thursday...